Progression and Regression of Abdominal Aortic Aneurysms in Mice

Abstract

Objective

Abdominal aortic aneurysm (AAA) is a significant medical problem with a high mortality rate. Nevertheless, the underlying mechanism for the progression and regression of AAA is unknown.

Methods

Experimental model of AAA was first created by porcine pancreatic elastase incubation around the infrarenal aorta of C57BL/6 mice. Then, AAA progression and regression were evaluated based on the diameter and volume of AAA. The aortas were harvested for hematoxylin-eosin staining (HE), orcein staining, sirius red staining, immunofluorescence analysis and perls’ prussian blue staining at the indicated time point. Finally, β-aminopropionitrile monofumarate (BAPN) was used to explore the underlying mechanism of the regression of AAA.

Results

When we extended the observation period to 100 days, we not only observed an increase in the AAA diameter and volume in the early stage, but also a decrease in the late stage. Consistent with AAA diameter and volume, the aortic thickness showed the same tendency based on HE staining. The elastin and collagen content first degraded and then regenerated, which corresponds to the early deterioration and late regression of AAA. Then, endogenous up-regulation of lysyl oxidase (LOX) was detected, accompanying the regression of AAA, as detected by an immunofluorescent assay. BAPN and LOX inhibitor considerably inhibited the regression of AAA, paralleling the degradation of elastin lamella and collagen.

Conclusion

Taken together, we tentatively conclude that endogenous re-generation of LOX played an influential role in the regression of AAA. Therefore, regulatory factors on the generation of LOX exhibit promising therapeutic potential against AAA.

Keywords

abdominal aortic aneurysm / disease progression / disease regression / elastogenesis / lysyl oxidase

References

[1] RookeTW, HirschAT, MisraS, et al.. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): A report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation, 2011, 124(18): 2020-2045

[2] ThompsonMM. Controlling the expansion of abdominal aortic aneurysms. Br J Surg, 2003, 90(8): 897-898

[3] WuJ, WangJ, LiXO, et al.. MicroRNA-145 Mediates the Formation of Angiotensin II-Induced Murine Abdominal Aortic Aneurysm. Heart Lung Circ, 2017, 26(6): 619-626

[4] GolledgeJ, NormanPE. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis, 2011, 217(1): 57-63

[5] SakalihasanN, LimetR, DefaweOD. . Abdominal aortic aneurysm. Lancet, 2005, 365(9470): 1577-1589

[6] WallinderJ, GeorgiouA, WanhainenA, et al.. Prevalence of Synchronous and Metachronous Aneurysms in Women With Abdominal Aortic Aneurysm. Eur J Vasc Endovasc Surg, 2018, 56(3): 435-440

[7] HeBM, ChaiXP, HeZB, et al.. HDL quantity and function are potential therapeutic targets for abdominal aortic aneurysm. Int J Cardiol, 2014, 176(3): 1070-1071

[8] GolledgeJ, MullerJ, DaughertyA, et al.. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol, 2006, 26(12): 2605-2613

[9] GolledgeJ, NormanPE, MurphyMP, et al.. Challenges and opportunities in limiting abdominal aortic aneurysm growth. J Vasc Surg, 2017, 65(1): 225-233

[10] RabkinSW. The role matrix metalloproteinases in the production of aortic aneurysm. Prog Mol Biol Transl Sci, 2017, 147: 239-265

[11] XiongJ, WangSM, ChenLH, et al.. Elastic fibers reconstructed using adenovirus-mediated expression of tropoelastin and tested in the elastase model of abdominal aortic aneurysm in rats. J Vasc Surg, 2008, 48(4): 965-973

[12] KieltyCM, SherrattMJ, ShuttleworthCA. Elastic fibres. J Cell Sci, 2002, 115: 2817-2828

[13] DaughertyA, CassisLA. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol, 2004, 24(3): 429-434

[14] ZaragozaC, Gomez-GuerreroC, Martin-VenturaJL, et al.. Animal models of cardiovascular diseases. J Biomed Biotechnol, 2011, 2011: 497841

[15] BhamidipatiCM, MehtaGS, LuG, et al.. Development of a novel murine model of aortic aneurysms using peri-adventitial elastase. Surgery, 2012, 152(2): 238-246

[16] Flurkey K, Currer JM, Harrison DE. In: The Mouse in Biomedical Research 2nd Edition. Fox JG, et al, eds. The Mouse in Aging Research. Burlington: American College Laboratory Animal Medicine (Elsevier), 2007: 637–672

[17] NaitoS, VonEschenbachAC, GiavazziR, et al.. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res, 1986, 46(8): 4109-4115

[18] HuCJ, ZhouL, CaiY. Dihydroartemisinin induces apoptosis of cervical cancer cells via upregulation of RKIP and downregulation of bcl-2. Cancer Biol Ther, 2014, 15(3): 279-288

[19] WagenseilJE, MechamRP. Vascular extracellular matrix and arterial mechanics. Physiol Rev, 2009, 89(3): 957-989

[20] KavazosK, NataatmadjaM, WalesKM, et al.. Dietary Supplementation with Omega-3 Polyunsaturated Fatty Acids Modulate Matrix Metalloproteinase Immunoreactivity in a Mouse Model of Pre-abdominal Aortic Aneurysm. Heart Lung Circ, 2015, 24(4): 377-385

[21] ArnaudC, BouyonS, RecoquillonS, et al.. Nonmuscle myosin light chain kinase: A key player in intermittent hypoxia-induced vascular alterations. J Am Heart Assoc, 2018, 7(3): e007893

[22] Coquand-GanditM, JacobMP, FhayliW, et al.. Chronic treatment with minoxidil induces elastic fiber neosynthesis and functional improvement in the aorta of aged mice. Rejuvenation Res, 2017, 20(3): 218-230

[23] KaganHM, LiW. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem, 2003, 88(4): 660-672

[24] MakiJM, RasanenJ, TikkanenH, et al.. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation, 2002, 106(19): 2503-2509

[25] Yokoyama U, Ishikawa Y. In: Akashi M, eds. Engineered Cell Manipulation for Biomedical Application. Tokyo: Springer, 2014:159–174.

[26] SchmelzerCEH, HeinzA, TroiloH, et al.. Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin. Faseb J, 2019, 33(4): 5468-5481

[27] Barry-HamiltonV, SpanglerR, MarshallD, et al.. Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med, 2010, 16(9): 1009-1017

[28] BignonM, Pichol-ThievendC, HardouinJ, et al.. Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane. Blood, 2011, 118(14): 3979-3989

[29] LeeVS, HalabiCM, HoffmanEP, et al.. Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans. Proc Natl Acad Sci USA, 2016, 113(31): 8759-8764

[30] YoshimuraK, AokiH, IkedaY, et al.. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase in mice. Ann N Y Acad Sci, 2006, 1085: 74-81